Canonical HH target genes such as PTCH1, GLI1, and GLI2 were not reliable markers of BCC-associated cells, likely due to their lower expression levels and the limitations of the 10X Genomics platform—which relies on the chemistry used and mainly capturing highly expressing mRNAs. The gene discussed is PTCH1; the disease is skin basal cell carcinoma.